Top

Published in:

04-10-2022 | COVID-19 | IM-Point of view

Monkeypox outbreak: after COVID-19, another challenge for the hemostatic system?

Authors: Marco Marietta, Valeria Coluccio, Mario Luppi

Published in: Internal and Emergency Medicine | Issue 8/2022

Excerpt

The huge amount of studies published in the last two year on the thrust of the COVID-19 pandemic shed further light on the already known relationships between viral infections and the hemostatic system [1]. Indeed, the analysis of pathogenetic mechanisms behind the COVID-associated coagulopathy (CAC) greatly improved our knowledge of the framework linking viral infection with endothelial inflammation, prothrombotic transformation, and barrier dysfunction [2]. …

Iba T, Levy JH, Levi M (2022) Viral-induced inflammatory coagulation disorders: preparing for another epidemic. Thromb Haemost. https://doi.org/10.1055/a-1562-7599CrossRefPubMed

Flaumenhaft R, Enjyoji K, Schmaier AA (2022) Vasculopathy in COVID-19. Blood. https://doi.org/10.1182/blood.2021012250CrossRefPubMed

Marietta M, Coluccio V, Luppi M (2022) Potential mechanisms of vaccine-induced thrombosis. Eur J Int Medicine. https://doi.org/10.1016/j.ejim.2022.08.002CrossRef

Sakurai F, Tachibana M, Mizuguchi H (2022) Adenovirus vector-based vaccine for infectious diseases. Drug Metab Pharmacokinet. https://doi.org/10.1016/j.dmpk.2021.100432CrossRefPubMed

Watanabe M, Nishikawaji Y, Kawakami H, Kosai KI (2021) Adenovirus biology, recombinant adenovirus, and adenovirus usage in gene therapy. Viruses. https://doi.org/10.3390/v13122502CrossRefPubMedPubMedCentral

Wenham C, Eccleston-Turner M (2022) Monkeypox as a PHEIC: implications for global health governance. Lancet. https://doi.org/10.1016/S0140-6736(22)01437-4CrossRefPubMedPubMedCentral

Di Giulio DB, Eckburg PB (2004) Human monkeypox: an emerging zoonosis. Lancet Infect Dis. https://doi.org/10.1016/s1473-3099(03)00856-9CrossRefPubMedPubMedCentral

Guarner J, Del Rio C, Malani PN (2022) Monkeypox in 2022—what clinicians need to know. JAMA. https://doi.org/10.1001/jama.2022.10802CrossRefPubMed

Thakur S, Kelkar D, Garg S, Raina SK, Lateef F, Gilada I et al (2022) Why should RNA viruses have all the fun—monkeypox, a close relative of smallpox and a DNA virus. J Glob Infect Dis. https://doi.org/10.4103/jgid.jgid_104_22CrossRefPubMedPubMedCentral

10.

Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, SHARE-net Clinical Group et al (2022) Monkeypox virus infection in humans across 16 countries—April–June 2022. N Engl J Med. https://doi.org/10.1056/NEJMoa2207323CrossRefPubMed

11.

Kmiec D, Kirchhoff F (2022) Monkeypox: a new threat? Int J Mol Sci. https://doi.org/10.3390/ijms23147866CrossRefPubMedPubMedCentral

12.

Levy JM, Iba T (2021) COVID-19 coagulopathy: is it disseminated intravascular coagulation? Intern Emerg Med. https://doi.org/10.1007/s11739-020-02601-yCrossRef

13.

Breman JB, Henderson DA (2002) Diagnosis and management of smallpox. N Engl J Med. https://doi.org/10.1056/NEJMra020025CrossRefPubMed

14.

Schultz D, Sagartzb JE, Husoc DL, Bullera RML (2009) Experimental infection of an African dormouse (Graphiurus kelleni) with monkeypox virus. Virology. https://doi.org/10.1016/j.virol.2008.09.025CrossRefPubMed

15.

Mucker EM, Chapman J, Huzella LM, Huggins JW, Shamblin J, Robinson CG, Hensley LE (2015) Susceptibility of marmosets (Callithrix jacchus) to monkeypox virus: a low dose prospective model for monkeypox and smallpox disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0131742CrossRefPubMedPubMedCentral

16.

Mucker EM, Wollen-Roberts SE, Kimmel A, Shamblin J, Sampey D, Hooper JW (2018) Intranasal monkeypox marmoset model: prophylactic antibody treatment provides benefit against severe monkeypox virus disease. PLoS Negl Trop Dis. https://doi.org/10.1371/journal.pntd.0006581CrossRefPubMedPubMedCentral

17.

Basler CF (2017) Molecular pathogenesis of viral hemorrhagic fever. Semin Immunopathol. https://doi.org/10.1007/s00281-017-0637-xCrossRefPubMedPubMedCentral

18.

Iannetta M, Di Caro A, Nicastri E, Vairo F, Masanja H, Kobinger G et al (2019) Viral hemorrhagic fevers other than Ebola and Lassa. Infect Dis Clin North Am. https://doi.org/10.1016/j.idc.2019.08.003CrossRefPubMed

19.

Casadevall A (2020) Climate change brings the specter of new infectious diseases. J Clin Invest. https://doi.org/10.1172/JCI135003CrossRefPubMedPubMedCentral

Title: Monkeypox outbreak: after COVID-19, another challenge for the hemostatic system?
Authors: Marco Marietta
Valeria Coluccio
Mario Luppi
Publication date: 04-10-2022
Publisher: Springer International Publishing
Keywords: COVID-19
Ebola Virus
Hantavirus
COVID-19
Smallpox
Published in: Internal and Emergency Medicine / Issue 8/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-022-03112-8

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Monkeypox outbreak: after COVID-19, another challenge for the hemostatic system?

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2022

Infections as predictors of NAFLD progression

Predictors of clinical outcomes of hospitalized patients with Covid-19: focusing on pre-existing liver disease

An unusual case of chronic diarrhea: a case report

Hospital characteristics associated with COVID-19 mortality: data from the multicenter cohort Brazilian Registry

Lung ultrasound in the follow-up of severe COVID-19 pneumonia: six months evaluation and comparison with CT

Frailty assessment in emergency medicine using the Clinical Frailty Scale: a scoping review

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page